Universe Pharmaceuticals Net Debt Growth & History (UPC)

Universe Pharmaceuticals's net debt was −$24.34B for fiscal 2025.

View full Universe Pharmaceuticals company overview

Universe Pharmaceuticals annual net debt history

Universe Pharmaceuticals annual net debt

Fiscal yearPeriod endedNet debtChangeGrowth
20252025-09-30−$24.34B−$694.1M
20242024-09-30−$23.64B−$23.64B
20232023-09-30$197,209$2.0M
20222022-09-30−$1.8M$2.0M
20212021-09-30−$3.7M$3.7M
20202020-09-30−$7.4M

Universe Pharmaceuticals net debt trends

Over the last five fiscal years, Universe Pharmaceuticals's net debt decreased from −$7.4M to −$24.34B, a change of −$24.33B. The latest reported quarter, Q2 2026, shows −$18.0M.

About the metric

What net debt means

Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.

Calculation and source

How net debt is calculated

TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Universe Pharmaceuticals source filings ↗

Community posts

It’s quiet here.

No posts about UPC yet. Start the conversation.

Write the first post